Top Investors’ Stock Portfolio: 5 Small-Cap Stocks To Buy

In this article, we discuss the best small-cap stocks to buy. If you want to read our detailed analysis of the small-cap stocks, go directly and see Top Investors’ Stock Portfolio: 10 Small-Cap Stocks To Buy. 

5. Amicus Therapeutics, Inc. (NASDAQ:FOLD)

Number of Hedge Fund Holders: 34
Market Cap: $2.9 billion

Amicus Therapeutics, Inc. (NASDAQ:FOLD) is an American biopharmaceutical company that ranks fifth on our list of the best small-cap stocks to buy.

Perceptive Advisors is the largest shareholder of Amicus Therapeutics, Inc. (NASDAQ:FOLD) in Q2, owning shares worth $222.8 million. On the whole, the hedge fund sentiment remained positive for the company in Q2, as 34 hedge funds tracked by Insider Monkey were bullish on the company, compared with 30 in the previous quarter. The total value of these stakes is $832.5 million.

This September, Cowen reiterated an Outperform rating on Amicus Therapeutics, Inc. (NASDAQ:FOLD), with a $29 price target. The stock returned 10.83% in the past six months.

Carillon Tower Advisers mentioned Amicus Therapeutics, Inc. (NASDAQ:FOLD) in its Q1 2021 investor letter. Here is what the firm has to say:

“Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering novel high-quality medicines for people living with rare metabolic diseases. The firm’s shares slumped after it reported disappointing results in the phase three trial for its drug to be used in the treatment of late-onset Pompe disease (LOPD). Unfortunately, the trial data did not generate statistical significance in the primary endpoint.”